Blueprint Medicines saw the highest growth of 1.28% in patent filings in May and 1.28% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.69% and grants by 1.28%. GlobalData’s DataBook provides a comprehensive analysis of Blueprint Medicines’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Blueprint Medicines has been focused on protecting inventions in European Patent Office(EPO) with ten publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings and grants with nearly 33% filings and 8% grants. The European Patent Office(EPO), United States(US), Hungary(HU), and Spain(ES) patent Office are among the top ten patent offices where Blueprint Medicines is filings its patents. Among the top granted patent authorities, Blueprint Medicines has 31% of its grants in United States(US), 23% in Spain(ES) and 15% in Croatia(HR).
Roche could be the strongest competitor for Blueprint Medicines
Patents related to rare diseases and climate change lead Blueprint Medicines's portfolio
Blueprint Medicines has the highest number of patents in rare diseases followed by, climate change. For rare diseases, nearly 88% of patents were filed and 100% of patents were granted in Q2 2024.
Leukemia related patents lead Blueprint Medicines portfolio followed by systemic mastocytosis, and gastrointestinal stromal tumor (gist)
Blueprint Medicines has highest number of patents in leukemia followed by systemic mastocytosis, gastrointestinal stromal tumor (gist), ovarian cancer, and colon cancer. For leukemia, nearly 6% of patents were filed and 5% of patents were granted in Q2 2024.
For comprehensive analysis of Blueprint Medicines's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
